Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-039179
Filing Date
2012-07-12
Accepted
2012-07-12 15:44:08
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v317307_10k.htm 10-K 1177120
2 EXHIBIT 31.1 v317307_ex31-1.htm EX-31.1 9192
3 EXHIBIT 31.2 v317307_ex31-2.htm EX-31.2 9211
4 EXHIBIT 32.1 v317307_ex32-1.htm EX-32.1 5598
5 GRAPHIC pg4.jpg GRAPHIC 42888
6 GRAPHIC pg5.jpg GRAPHIC 121747
  Complete submission text file 0001144204-12-039179.txt   4870957

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ck0001341293-20111231.xml EX-101.INS 761983
8 XBRL TAXONOMY EXTENSION SCHEMA ck0001341293-20111231.xsd EX-101.SCH 23649
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001341293-20111231_cal.xml EX-101.CAL 40310
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001341293-20111231_def.xml EX-101.DEF 137000
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001341293-20111231_lab.xml EX-101.LAB 181269
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001341293-20111231_pre.xml EX-101.PRE 161962
Mailing Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021
Business Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021 516-482-1200
Neogenix Oncology Inc (Filer) CIK: 0001341293 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD
Type: 10-K | Act: 34 | File No.: 000-53963 | Film No.: 12959369
SIC: 2835 In Vitro & In Vivo Diagnostic Substances